0001415889-24-013471.txt : 20240517 0001415889-24-013471.hdr.sgml : 20240517 20240517161019 ACCESSION NUMBER: 0001415889-24-013471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlong Tammy CENTRAL INDEX KEY: 0001984204 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 24959749 MAIL ADDRESS: STREET 1: C/O ELEVATION ONCOLOGY, INC. STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7163711125 MAIL ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 form4-05172024_040501.xml X0508 4 2024-05-15 0001783032 Elevation Oncology, Inc. ELEV 0001984204 Furlong Tammy C/O ELEVATION ONCOLOGY, INC. 101 FEDERAL STREET, SUITE 1900 BOSTON MA 02110 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-05-15 4 M 0 300 A 1097 D Common Stock 2024-05-15 4 F 0 100 3.73 D 997 D Restricted Stock Unit 2024-05-15 4 M 0 300 0 D Common Stock 300 3300 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The RSUs do not expire; they either vest or are canceled prior to the vesting date. /s/ Robert Yang, Attorney-in-Fact 2024-05-17